High Standard USP 98% Raw Powder Atomoxetine hydrochloride HCl CAS 82248-59-7
TDS 3 Inquiries
82248-59-7
Pharmaceutical Grade
99%
SHANGHAI
HyperChem
1kg/Bag, 25kg/drum
2025-03-19
Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceAtomoxetine Hcl(LY 139603; Tomoxetine Hcl) is a potent and selective noradrenalin re-uptake inhibitor (Ki values are 5, 77 and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively). IC50 value: 5 nM (Ki for human NET)Target: NETAtomoxetine displays minimal affinity for a range of other neurotransmitter receptors and transporters (Ki > 1 μM). Atomoxetine is antidepressant and a commonly used non-stimulant treatment for Attention deficit hyperactivity disor
Atomoxetine hydrochloride is the hydrochloride salt of atomoxetine. It has a role as an antidepressant and an adrenergic uptake inhibitor. It contains an atomoxetine.|Atomoxetine is a selective norepinephrine reuptake inhibitor used primarily for therapy of attention deficit hyperactivity disorder. Atomoxetine has been linked to a low rate of serum aminotransferase elevations and to rare cases of acute, clinically apparent liver injury.|Atomoxetine Hydrochloride is the hydrochloride salt of atomoxetine, a phenoxy-3-propylamine derivative and selective non-stimulant, norepinephrine reuptake inhibitor with cognitive-enhancing activity. Although its precise mechanism of action is unknown, atomoxetine appears to selectively inhibit the pre-synaptic norepinephrine transporter, resulting in inhibition of the presynaptic reabsorption of norepinephrine and prolongation of norepinephrine activity in the synaptic cleft. The effect on cognitive brain function may result in improved attention and decreased impulsivity and activity levels.|A propylamine derivative and selective ADRENERGIC UPTAKE INHIBITOR that is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.Certificates-
TDS
Basic Info-
Product Name:
Atomoxetine hydrochloride
Other Name:Benzenepropanamine,N-methyl-γ-(2-methylphenoxy)-,hydrochloride (1:1),(γR)-;Benzenepropanamine,N-methyl-γ-(2-methylphenoxy)-,hydrochloride,(R)-;Benzenepropanamine,N-methyl-γ-(2-methylphenoxy)-,hydrochloride,(γR)-;LY 139603;Tomoxetine hydrochloride;(R)-(-)-Tomoxetine hydrochloride;(R)-Tomoxetine hydrochloride;Atomoxetine hydrochloride;(R)-(-)-N-Methyl-3-[(2-methylphenyl)oxy]-3-phenyl-1-aminopropane hydrochloride;Strattera;(R)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropylamine hydrochloride;Atemoxetine hydrochloride;(R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride
CAS No.:82248-59-7
Molecular Formula:C17H21NO.ClH
InChIKeys:InChIKey=LUCXVPAZUDVVBT-UNTBIKODSA-N
Molecular Weight:291.82
Exact Mass:291.138977
EC Number:200-659-6
UNII:57WVB6I2W0
DSSTox ID:DTXSID2044266
NCI Thesaurus Code:C47405
HScode:2922299090
Categories:
Characteristics-
PSA:
21.3
XLogP3:4.91750
Appearance:solid
Melting Point:160-161 °C
Boiling Point:389°C at 760 mmHg
Flash Point:9℃
Water Solubility:In water, 54.64 mg/L at 25 deg C (est)
Storage Conditions:2-8°C
Vapor Pressure:1.31X10-5 mm Hg at 25 deg C (est)
Specific rotation:D25 -38.01°; 36525 -177.26° (c = 1 in methanol); D23 -41.37° (c = 1.02 in methanol); D25 -40.3° (c = 0.94 in ethanol)
Collision Cross Section:162.4 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 3, Oral
Serious eye damage, Category 1
Acute toxicity - Category 2, Inhalation
Hazardous to the aquatic environment, short-term (Acute) - Category Acute 1
Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 1
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Danger
Hazard statement(s) H301 Toxic if swallowed
H318 Causes serious eye damage
H330 Fatal if inhaled
H400 Very toxic to aquatic life
H410 Very toxic to aquatic life with long lasting effects
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
P284 [In case of inadequate ventilation] wear respiratory protection.
P273 Avoid release to the environment.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P317 Get medical help.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P316 Get emergency medical help immediately.
P320 Specific treatment is urgent (see ... on this label).
P391 Collect spillage.
Storage P405 Store locked up.
P403+P233 Store in a well-ventilated place. Keep container tightly closed.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements
-
Location:
Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2013
-
Certifications:
Certification Report by Bureau Veritas
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted
Chile
Atomoxetine hydrochloride
2 KG Apr 17, 2026
Guatemala
Atomoxetine HCl
1 KG Dec 31, 2023
United States
atomoxetine
100 MG Apr 9, 2026 Post an enquiry for this product